Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 28, 2014; 20(44): 16550-16558
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16550
Retroperitoneal disorders associated with IgG4-related autoimmune pancreatitis
Noboru Hara, Makoto Kawaguchi, Keisuke Takeda, Yoh Zen
Noboru Hara, Keisuke Takeda, Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan
Noboru Hara, Division of Molecular Oncology, Department of Signal Transduction Research, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan
Makoto Kawaguchi, Division of Diagnostic Pathology, Niigata Rousai Hospital, Niigata 951-8510, Japan
Yoh Zen, Institute of Liver Studies, King’s College Hospital, SE5 9RS London, United Kingdom
Author contributions: Hara N designed the study and wrote the manuscript; Takeda K assisted in literature searches and data acquisition; Kawaguchi M performed pathological evaluations; Zen Y was involved in editing the manuscript.
Correspondence to: Noboru Hara, MD, PhD, Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University, Asahimachi 1, Niigata 951-8510, Japan. harasho@med.niigata-u.ac.jp
Telephone: +81-25-2272287 Fax: +81-25-2270784
Received: January 20, 2014
Revised: February 27, 2014
Accepted: April 28, 2014
Published online: November 28, 2014
Abstract

IgG4-related autoimmune pancreatitis is frequently accompanied by relevant lesions in the genitourinary tract and retroperitoneal organs, which cause various clinical problems, ranging from non-specific back pain or bladder outlet obstruction to renal failure. The diagnosis of IgG4-related retroperitoneal fibrosis requires a multidisciplinary approach, including serological tests, histological examination, imaging analysis, and susceptibility to steroid therapy. Radiological examinations are helpful to diagnose this condition, but surgical resection is occasionally unavoidable to exclude malignancy, particularly for patients with isolated retroperitoneal involvement. Steroid therapy is the treatment of choice for this condition, the same as for other manifestations of IgG4-related disease. For patients with severe ureteral obstruction, additional ureteral stenting needs to be considered prior to steroid therapy to preserve the renal function. Some papers have suggested that IgG4-related disease can affect male reproductive organs including the prostate and testis. IgG4-related prostatitis usually causes lower urinary tract symptoms, such as dysuria and pollakisuria. Patients sometimes state that corticosteroids given for IgG4-related disease at other sites relieve their lower urinary tract symptoms, which leads us to suspect prostatic involvement in this condition. Because of the limited number of publications available, further studies are warranted to better characterize IgG4-related disease in male reproductive organs.

Keywords: IgG4, Autoimmune pancreatitis, Retroperitoneum, Genitourinary tract, Management

Core tip: Patients with IgG4-related autoimmune pancreatitis frequently have associated conditions involving genitourinary organs. Since clinical presentations and imaging findings vary among patients, the differential diagnoses are broad. Serum IgG4 elevation is highly sensitive but not entirely specific for this condition, which is one reason why the diagnosis should be established in a multidisciplinary way. Although recent radiological advances have facilitated the effective characterization of IgG4-related retroperitoneal fibrosis, surgical resection is occasionally necessary to exclude malignancies. In addition to steroid therapy, ureteral stenting is required for patients with severe ureteral obstruction. A new concept of IgG4-related prostatitis is being increasingly recognized.